论文部分内容阅读
目的:对茵栀黄口服液作为辅助药物在肝炎治疗中的退黄疸作用以及安全性探究。方法:选取50例在我院就诊的肝炎患者作为研究对象,首先把50例患者进行分组,分为治疗组和对照组,每组分别为25人,分组采取随机的方法。对治疗组实行为期15天的茵栀黄口服液口服辅助治疗,对照组则没有使用茵栀黄口服液进行辅助的治疗。依据胆红素的检测值将黄疸分为高、中、低三个水平。观察治疗组肝炎患者在治疗期间胆红素值的变化情况以及黄疸的消退时间。结果:治疗组的肝炎患者在较短时间内黄疸就消退,与对照组的差异具有统计学意义(P<0.05);治疗组的胆红素处于中、高水平的肝炎患者经过治疗后胆红素值都明显下降;胆红素值处于低水平的肝炎患者其胆红素值下降不够明显。在治疗期间,接受治疗的肝炎患者除了大便次数增多外无其他不良反应。结论:口服茵栀黄口服液可以降低高胆红素血症高峰值,缩短黄疸消退时间,且用药安全。
Objective: To investigate the effect and safety of Yinzhihuang Oral Liquid as a supplementary drug in the treatment of hepatitis. Methods: Fifty patients with hepatitis treated in our hospital were selected as research objects. First, 50 patients were divided into treatment group and control group, with 25 patients in each group and randomly divided into groups. The treatment group, a 15-day oral administration of Yinzhihuang oral adjuvant therapy, the control group did not use Yinzhihuang oral liquid adjuvant therapy. Based on the detection of bilirubin will be divided into high, medium and low jaundice levels. Observe the change of bilirubin value and jaundice time of treatment group patients with hepatitis during treatment. Results: The patients with hepatitis in the treatment group regressed jaundice in a relatively short period of time, with statistical significance (P <0.05). The bilirubin in the treatment group was moderate to high The value of all significantly decreased; bilirubin values in patients with low levels of hepatitis b decreased its bilirubin value is not obvious enough. During treatment, patients receiving hepatitis treated had no adverse effects other than an increase in stool frequency. Conclusion: Oral Yin Zhi Huang oral solution can reduce the peak value of hyperbilirubinemia, shorten the jaundice subsided time, and medication safety.